These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 33360039)
1. Serum biomarkers of cerebral cellular stress after self-limiting tonic clonic seizures: An exploratory study. Nass RD; Akgün K; Elger C; Reichmann H; Wagner M; Surges R; Ziemssen T Seizure; 2021 Feb; 85():1-5. PubMed ID: 33360039 [TBL] [Abstract][Full Text] [Related]
2. Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizures. Akel S; Asztely F; Banote RK; Axelsson M; Zetterberg H; Zelano J Epilepsia; 2023 Oct; 64(10):2690-2700. PubMed ID: 37469165 [TBL] [Abstract][Full Text] [Related]
4. Time courses of HMGB1 and other inflammatory markers after generalized convulsive seizures. Nass RD; Wagner M; Surges R; Holdenrieder S Epilepsy Res; 2020 May; 162():106301. PubMed ID: 32126476 [TBL] [Abstract][Full Text] [Related]
5. CSF and Serum Biomarkers of Cerebral Damage in Autoimmune Epilepsy. Nass RD; Akgün K; Dague KO; Elger CE; Reichmann H; Ziemssen T; Surges R Front Neurol; 2021; 12():647428. PubMed ID: 33935944 [No Abstract] [Full Text] [Related]
6. Brain-specific biomarkers in urine as a non-invasive approach to monitor neuronal and glial damage. Kohlhase K; Frank F; Wilmes C; Koerbel K; Schaller-Paule MA; Miles M; Betz C; Steinmetz H; Foerch C Eur J Neurol; 2023 Mar; 30(3):729-740. PubMed ID: 36409153 [TBL] [Abstract][Full Text] [Related]
7. Brain injury markers in new-onset seizures in adults: A pilot study. Eriksson H; Banote RK; Larsson D; Blennow K; Zetterberg H; Zelano J Seizure; 2021 Nov; 92():62-67. PubMed ID: 34455195 [TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis. Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123 [TBL] [Abstract][Full Text] [Related]
10. A pharmacokinetic and biomarker study of delayed-release dimethyl fumarate in subjects with secondary progressive multiple sclerosis: evaluation of cerebrospinal fluid penetration and the effects on exploratory biomarkers. Edwards KR; Kamath A; Button J; Kamath V; Mendoza JP; Zhu B; Plavina T; Woodward C; Penner N Mult Scler Relat Disord; 2021 Jun; 51():102861. PubMed ID: 33773271 [TBL] [Abstract][Full Text] [Related]
11. Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid β up to 90 Days after Traumatic Brain Injury. Bogoslovsky T; Wilson D; Chen Y; Hanlon D; Gill J; Jeromin A; Song L; Moore C; Gong Y; Kenney K; Diaz-Arrastia R J Neurotrauma; 2017 Jan; 34(1):66-73. PubMed ID: 27312416 [TBL] [Abstract][Full Text] [Related]
12. Acute metabolic effects of tonic-clonic seizures. Nass RD; Zur B; Elger CE; Holdenrieder S; Surges R Epilepsia Open; 2019 Dec; 4(4):599-608. PubMed ID: 31819916 [TBL] [Abstract][Full Text] [Related]
13. Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity. Högel H; Rissanen E; Barro C; Matilainen M; Nylund M; Kuhle J; Airas L Mult Scler; 2020 Feb; 26(2):210-219. PubMed ID: 30570436 [TBL] [Abstract][Full Text] [Related]
14. Combination of plasma amyloid beta Verberk IMW; Thijssen E; Koelewijn J; Mauroo K; Vanbrabant J; de Wilde A; Zwan MD; Verfaillie SCJ; Ossenkoppele R; Barkhof F; van Berckel BNM; Scheltens P; van der Flier WM; Stoops E; Vanderstichele HM; Teunissen CE Alzheimers Res Ther; 2020 Sep; 12(1):118. PubMed ID: 32988409 [TBL] [Abstract][Full Text] [Related]
15. Association of Blood Biomarkers With Acute Sport-Related Concussion in Collegiate Athletes: Findings From the NCAA and Department of Defense CARE Consortium. McCrea M; Broglio SP; McAllister TW; Gill J; Giza CC; Huber DL; Harezlak J; Cameron KL; Houston MN; McGinty G; Jackson JC; Guskiewicz K; Mihalik J; Brooks MA; Duma S; Rowson S; Nelson LD; Pasquina P; Meier TB; ; Foroud T; Katz BP; Saykin AJ; Campbell DE; Svoboda SJ; Goldman J; DiFiori J JAMA Netw Open; 2020 Jan; 3(1):e1919771. PubMed ID: 31977061 [TBL] [Abstract][Full Text] [Related]
16. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort. Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051 [TBL] [Abstract][Full Text] [Related]
17. Serum Neurofilament Light, Glial Fibrillary Acidic Protein and Tau Are Possible Serum Biomarkers for Activity of Brain Metastases and Gliomas. Hepner A; Porter J; Hare F; Nasir SS; Zetterberg H; Blennow K; Martin MG World J Oncol; 2019 Oct; 10(4-5):169-175. PubMed ID: 31636790 [TBL] [Abstract][Full Text] [Related]
18. [Expression levels of ubiquitin C-terminal hydrolase-L1 and serum glial fibrillary acidic protein and its clinical significance in patients with acute cerebral infarction]. Hu C; Yang X; Mao D; Lou S; Dai Q; Chen J; Cheng X; Wang S Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 42(3):284-290. PubMed ID: 28364101 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis. Robinson T; Abdelhak A; Bose T; Meinl E; Otto M; Zettl UK; Dersch R; Tumani H; Rauer S; Huss A Cells; 2020 Nov; 9(12):. PubMed ID: 33255854 [TBL] [Abstract][Full Text] [Related]
20. Serum Glial Fibrillary Acidic Protein Predicts Tissue Glial Fibrillary Acidic Protein Break-Down Products and Therapeutic Efficacy after Penetrating Ballistic-Like Brain Injury. Boutté AM; Deng-Bryant Y; Johnson D; Tortella FC; Dave JR; Shear DA; Schmid KE J Neurotrauma; 2016 Jan; 33(1):147-56. PubMed ID: 25789543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]